Rotational behavior in dopamine nigrostriatal denervated rats: Effects of a wide range of time intervals between apomorphine administrations

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 3, 1999, Pages 481-485

  Casas, Miguel ^a   Prat, Gemma ^a   Robledo, Patricia ^a   Jané, Francesc ^a  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

Author keywords

Animal model; Dopamine agonists; Rotational behavior; Sensitization; Time interval between administrations; Tolerance; Turning behavior

Indexed keywords

APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; APOMORPHINE; DENERVATION; DOPAMINE; DOPAMINE AGONISTS; MALE; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; STEREOTYPED BEHAVIOR; SUBSTANTIA NIGRA; SYMPATHOLYTICS; TIME FACTORS;

EID: 0032978053     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00216-0     Document Type: Article

References (35)

1. Asin K.E., Bednarz L., Nikkel A., Perner R. Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa. J. Pharmacol. Exp. Ther. 273:1995;1483-1490.
2. Barone P., Popoli M., Morelli M., Cicarelli G., Campanella G., Di Chiara G. Dopamine mediated responses in 6-hydroxydopamine lesioned rat involve changes of the signal transduction. J. Neural Transm. 45:1995;83-90.
3. Carey R.J. Conditioned rotational behavior in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra. Brain Res. 365:1986;379-382.
4. Carey R.J. Chronic L-DOPA treatment in the unilateral 6-OHDA rat. Evidence for behavioural sensitization and biochemical tolerance Brain Res. 562:1991;205-214.
5. Casas M., Guix T., Prat G., Ferré S., Cadafalch J., Jané J. Conditioning of rotational behavior after the administration of a single dose of apomorphine in rats with unilateral denervation of the dopaminergic nigrostriatal pathway. Relevance to drug addiction Pharmacol. Biochem. Behav. 31:1989;605-609.
6. Castro R., Abreu P., Calzadilla C.H., Rodríguez M. Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval. Psychopharmacology (Berlin). 85:1985;333-339.
7. 2 receptor agonists on rotational behavior and dopamine receptor binding. Eur. J. Pharmacol. 236:1993;385-393.
8. Fenu S., Pinna A., Ongini E., Morelli M. Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur. J. Pharmacol. 321:1997;143-147.
9. Gancher S., Mayer A. Sensitization to apomorphine-induced rotational behavior in 6-OHDA-lesioned rats. Effects of NMDA antagonists on drug response Brain Res. 682:1995;63-68.
10. Gancher S., Crabbe J., Garland A., Lea E., Woodward W. Dose- and duration-dependent tolerance to rotational effects of apomorphine in a rat model of parkinsonism. J. Pharmacol. Exp. Ther. 272:1995;275-281.
11. Hefti F., Melamed E., Wurtman R.J. Partial lesions of the dopaminergic nigrostriatal system in rat brain. Biochemical characterization. Brain Res. 195:1980;123-137.
12. Hudson J.L., van Horne C.G., Strömberg I., Brock S., Clyton J., Masserano J., Hoffer B.J., Gerhardt G.A. Correlation of apomorphine-and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxidopamine lesioned rats. Brain Res. 626:1993;167-174.
13. Hudson J.L., Fong C.-H., Boyson S.J., Hoffer B.J. Conditioned apomorphine-induced turning in 6-OHDA-lesioned rats. Pharmacol. Biochem. Behav. 49:1994;147-154.
14. Klug J.M., Norman A.B. Long-term sensitization of apomorphine-induced rotational behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum. Pharmacol. Biochem. Behav. 46:1993;397-403.
15. König J.F.R., Klippel R.A. The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. 1963;R. E. Krieger Publishing Co. Inc, New York.
16. Loschmann P.A., Wullner U., Heneka M.T., Schulz J.B., Kunow M., Wachtel H., Klockgether T. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease. Synapse. 26:1997;381-391.
17. Luquin M.R., Laguna J., Herrero M.T., Obeso J.A. Behavioural tolerance to repeated apomorphine administration in parkinsonian monkeys. J. Neurol. Sci. 114:1993;40-44.
18. Morelli M., Di Chiara G. Agonist-induced homologous and heterologous sensitization to D-1-and D-2-dependent contraversive turning. Eur. J. Pharmacol. 141:1987;101-107.
19. Morelli M., Fenu S., Garau L., Di Chiara G. Time and dose dependence of the 'priming' of the expression of the dopamine receptor supersensibility. Eur. J. Pharmacol. 162:1989;329-335.
20. 1 receptor-adenylate cyclase complex after priming. Eur. J. Pharmacol. 180:1990;365-367.
21. Morelli M., Fenu S., Pinna A., Cozzolino A., Carta A., Di Chiara G. "Priming" to dopamine agonist-induced contralateral turning as a model of non-associative sensitization to the expression of the post-synaptic dopamine message. Behav. Pharmacol. 4:1993;389-397.
22. Norman A.B., Wyatt L.M., Hilderbrand J.P., Kolmonpunporn M., Moody C.A., Lehman M.N., Sanberg P.R. Sensitization of rotation behavior in rats with unilateral 6-hydroxydopamine or kainic acid-induced striatal lesions. Pharmacol. Biochem. Behav. 37:1990;755-759.
23. Oh J.D., Del Dotto P., Chase T.N. Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat. Neurosci. Lett. 228:1997;5-8.
24. 2 agonist stimulation in 6-Hydroxydopamine-lesioned rats. Neuroscience. 79:1997;79-93.
25. Pycock C.J. Turning behaviour in animals. Neuroscience. 8:1980;461-514.
26. Rouillard C., Bédard J.B. Specific D1 and D2 dopamine agonists have synergistic effects in the 6-hydroxydopamine circling model in the rat. Neuropharmacology. 27:1988;1257-1264.
27. Schwarting R.K.W., Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatment. Prog. Neurobiol. 50:1996;275-331.
28. Schwarting R.K.W., Huston J.P. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog. Neurobiol. 49:1996;215-266.
29. Silverman P.B. Sensitization and conditioned rotation. Apomorphine, quinpirole and SKF-38393 compared Neuroreport. 2:1991;669-672.
30. Silverman P.B., Ho B.T. Persistent behavioral effect of apomorphine in 6-hydroxydopamine-lesioned rats. Nature. 294:1981;475-477.
31. Silverman P.B., Bonate P.L. Role of conditioned stimuli in addiction. Johnson B.A., Roache J.D. Drug addiction and its treatment. Nexus of neuroscience and behavior. 1997;115-133 Lippincott-Raven, Philadelphia.
32. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta Physiol. Scand. 82(Suppl. 367):1971;69-93.
33. Ungerstedt U., Herrera-Marschitz M. Behavioural pharmacology of dopamine receptors mechanism. Stjärne L., Hedqvist P., Lagerkrantz H., Wenmalm A. Chemical neurotransmission. 75 years:1981;481-494 Academic Press, New York.
34. Ungerstedt U., Herrera-Marschitz M., Casas M. Are apomorphine, bromocriptine and methylxanthines agonists at the same dopamine receptor? Gessa G.L., Corsini G.U. Apomorphine and other dopaminomimetics, vol. 1. 1981;85-93 Raven Press, New York.
35. Winkler J.D., Weiss B. Reversal of supersensitive apomorphine-induced rotational behavior in mice by continuous exposure to apomorphine. J. Pharmacol. Exp. Ther. 238:1986;242-247.